The FDA has awarded De Novo certification to NigthWare which has developed a digital therapy to combat sleep disorders.
De Novo
A digital therapy for children with ADHD
Akili Interactive has received De Novo marketing authorization from the FDA for EndeavorRx, a therapeutic video game for children aged 8-12 years with ADHD (Attention Deficit Disorder/Hyperactivity Disorder).
Digital-health 